| Vuity (U.S.N.L.M.) | |||
|---|---|---|---|
| Dosing (presbyopia) | 1 drop in each eye once daily | ||
| Chem Specs | 1.25% pilocarpine hydrochloride | ||
| Quantities | 2.5ml dropper bottle | ||
| Cost | |||
| Class | anticholinergic | ||
| Action | Cholinergic muscarinic receptor agonist. | ||
| Usage | Indicated for the treatment of presbyopia in adults. Maximum effect after a little more than an hour declining to near baseline after about 6 hours. |
||
| Warnings | Warn patients about hazard of reduced vision with night driving or other situations involving reduced illumination. Retinal detachments reported in pseudophakes with pre-existing retinal detachment risk factors. Not recommended when iritis is present due to possible synechiae formation. |
||
| Contraindications | Hypersensitivity to active ingredient or excipients. | ||
| Pediatric use | n/a | ||
| Pregnancy | Category C. It is not known whether topically administered atropine sulfate can cause fetal harm. Oral administration of pilocarpine to pregnant rats throughout organogenesis and lactation did not produce adverse effects at clinically relevant doses. |
||
| According to AbbVie, pHast™ vehicle allows rapid adjustment to pH of the tear film, reducing stinging and improving availability. If taken with other eye drops allow 5 minutes between drops. |
|||